Trial intelligence / Profile preview

Paroxetine in PTSD and Substance Dependence

NCT00330239Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Jan 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paroxetine in post-traumatic stress disorder (PTSD), substance dependence, sponsored by Medical University of South Carolina. Started Jan 2003; status: completed.

02

Drugs

paroxetine
03

Conditions

post-traumatic stress disorder (PTSD)substance dependence

Beyond the preview

Go deeper on NCT00330239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00330239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call